2 years ago
APLS
AnalystsColleen KusyColleen Kusy's Stock Forecasts
AnalystsColleen Kusy
Sectors:
Industries:
Analyst Ranking
Bottom 6%
#4855 out of 5157 analysts
Average Return
-7.07%
Win Rate
36%18 out of 50
Risk vs Reward
Poor
Good
Colleen Kusy's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Iveric Bio IncISEE | +150.13% | $14.94 | $37.37 | 2022-09-07 - 2023-05-04 | Buy |
Ocular Therapeutix IncOCUL | +149.31% | $3.61 | $9.00 | 2023-09-14 - 2024-09-13 | Buy |
Climb Bio IncCLYM | +125.26% | $1.90 | $4.28 | 2025-08-15 - 2025-12-19 | Buy |
Surface Oncology IncSURF | +85.12% | $0.58 | $1.07 | 2023-05-04 - 2023-09-07 | Buy |
Oculis Holding AgOCS | +66.02% | $11.92 | $19.79 | 2024-06-11 - 2025-06-10 | Buy |
Colleen Kusy Analyst Color
Get additional color on Colleen Kusy's coverage of popular stocks
Colleen Kusy's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Argenx SeARGX | 1 | Hold | $858.00 | +0.35% | Downgrades | 5 days ago |
Nuvalent IncNUVL | 3 | Buy | $158.00 | +52.22% | Maintains | a month ago |
Cogent Biosciences IncCOGT | 1 | Hold | $34.00 | -14.03% | Maintains | a month ago |
Apellis Pharmaceuticals IncAPLS | 13 | Buy | $52.00 | +110.95% | Maintains | 2 months ago |
Ocular Therapeutix IncOCUL | 5 | Buy | $24.00 | +91.08% | Maintains | 3 months ago |
Climb Bio IncCLYM | 1 | Buy | $9.00 | +110.28% | Initiates Coverage On | 4 months ago |
Enliven Therapeutics IncELVN | 3 | Buy | $52.00 | +208.24% | Maintains | 6 months ago |
Agenus IncAGEN | 4 | Hold | $6.00 | +74.42% | Maintains | 7 months ago |
Oculis Holding AgOCS | 4 | Buy | $41.00 | +92.94% | Maintains | 9 months ago |
Coherus Oncology IncCHRS | 5 | Buy | $6.00 | N/A | Maintains | a year ago |
Spyre Therapeutics IncSYRE | 2 | Buy | $65.00 | N/A | Maintains | a year ago |
Mersana Therapeutics IncMRSN | 4 | Hold | $75.00 | N/A | Maintains | a year ago |
Oric Pharmaceuticals IncORIC | 1 | Buy | $25.00 | N/A | Reiterates | 2 years ago |
Surface Oncology IncSURF | 5 | Buy | $6.00 | N/A | Maintains | 3 years ago |
Iveric Bio IncISEE | 3 | Hold | $40.00 | N/A | Downgrades | 3 years ago |
Harpoon Therapeutics IncHARP | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Aveo Pharmaceuticals IncAVEO | 1 | Hold | $15.00 | N/A | Downgrades | 3 years ago |
Karyopharm Therapeutics IncKPTI | 1 | Buy | $210.00 | N/A | Maintains | 3 years ago |
Iovance Biotherapeutics IncIOVA | 2 | Buy | $34.00 | N/A | Maintains | 4 years ago |
Sab Biotherapeutics IncSABS | 1 | Buy | $230.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.